Amphetamine-Induced Dopamine Release Predicts 1-Year Outcome in First-Episode Psychosis: A Naturalistic Observation

Area of Science:

• Neuroscience
• Psychiatry
• Radiology

Background:

• The dopamine theory of schizophrenia posits that blocking dopamine D2/3 receptors with antipsychotics alleviates symptoms.
• A significant portion of patients with schizophrenia do not respond adequately to current antipsychotic treatments.
• Identifying predictors of treatment response is crucial for optimizing care in first-episode schizophrenia.

Purpose of the Study:

• To investigate d-amphetamine-induced dopamine release as a potential predictor of 1-year clinical outcomes in antipsychotic-naive patients with first-episode schizophrenia.
• To explore the relationship between dopamine system function and symptom severity and persistence.

Main Methods:

• Twenty-one antipsychotic-naive patients underwent [11C]-(+)-PHNO positron emission tomography scans.
• Dopamine release was estimated by comparing scans with and without d-amphetamine pretreatment.
• Clinical outcomes were assessed using the Positive and Negative Syndrome Scale (PANSS) over 1 year.

Main Results:

• Dopamine release in the ventral striatum was associated with reductions in positive symptoms.
• Dopamine release in the globus pallidus correlated with decreases in PANSS negative, general, and total symptom scores.
• Higher dopamine release in the substantia nigra/ventral tegmental area predicted greater reductions in general symptoms, while putamen binding correlated with negative symptom severity.

Conclusions:

• Exploratory results suggest a link between d-amphetamine-induced dopamine release and symptom severity and persistence in the first year of psychosis.
• These findings may offer insights into personalized treatment strategies for schizophrenia.